Stručni rad

Proposal for biologic drugs therapy in rheumatoid arthritis

Božidar Ćurković ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Đurđica Babić-Naglić ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Jadranka Morović-Vergles ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Branimir Anić ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Simeon Grazio ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Dušanka Martinović Kaliterna ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Marino Hanih ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska
Srđan Novak ; Hrvatsko reumatološko društvo, Hrvatski liječnički zbor, Zagreb, Hrvatska

Sažetak

Rheumatoid arthritis is a chronic, inflammatory disease with the prevalence about 1 %. Rheumatoid arthritis is characterized with synovitis, often evolve erosions of the joints, pain and functional deficit. Etiology is unknown, but the development of such autoimmune disease is due to genetic and environmental factors. Most of the patients with diagnosis of rheumatoid arthritis use nonbiologic disease modifying antirheumatic drugs. Advances in the undersstanding of the disease process have led to the development of biological agents to treat rheumatoid arthritis. With the use of biologic agents we wish to evolve the goal of therapy from that of symptomatiic relief to clinical remission. Biologic drugs have documented, fast and continuous efficacy with generaly well accepted safety profile. On behalf of Croatian Society for Rheumatology we propose recommendations for the biologic therapy in rheumatoid arthritis.

Ključne riječi

rheumatoid arthritis; biologic drugs; recommendations

Hrčak ID:

124784

URI

https://hrcak.srce.hr/124784

Datum izdavanja:

1.7.2010.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.716 *